Class Action Lawsuit Filed Against Cellebrite Following Financial Guidance Miss
What happened
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential claims on behalf of purchasers of Cellebrite DI Ltd. The investigation follows news that Cellebrite reported second-quarter 2026 financial results that missed its prior guidance for Annual Recurring Revenue.
From pr-inside.com
Why it matters
The lawsuit relates to financial disclosures made by Cellebrite, which had previously lowered its full-year ARR guidance and announced the replacement of CEO Thomas E. Hogan. Following these announcements, Cellebrite's stock price dropped 29.18% to $10.80 on August 13, 2026.
From pr-inside.com
Who's involved
- CellebriteThe company subject to the investigation and class action claims.
- Thomas E. HoganThe former CEO of Cellebrite, whose replacement was announced amid the financial issues.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- CellebriteSpeculative
Investors in Cellebrite might face increased legal costs or changes in funding due to the class action investigation.
Keep exploring
The entities involved
-
Cellebrite
Israeli digital intelligence company
-
New York City
most populous city in the United States